PPIDT00042
Drug Information
| Name | Insulin glargine |
|---|---|
| Sequence | GIVEQCCTSICSLYQLENYCG |
| DrugBank_ID | DB00047 |
| Type | biotech |
| Indication | Insulin glargine is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.[L12474,L43532,L43587] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Parenteral |
100 IU/ML
|
| Injection | — |
100 IU
|
| Solution | Subcutaneous |
100 IU
|
| Solution | Subcutaneous |
100 iu/1ml
|
| Solution | Subcutaneous |
100 UI
|
| Injection | — |
100 IU/ml
|
| Solution | Subcutaneous |
3.640 mg
|
| Injection | Intramuscular |
|
| Injection | Intramuscular |
100 U/mL
|
| Solution | Subcutaneous |
100 IU/mL
|
| Injection, solution | Subcutaneous |
300 [iU]/1mL
|
| Injection, solution | Parenteral; Subcutaneous |
100 U/ML
|
| Injection, solution | Parenteral; Subcutaneous |
100 IU/ML
|
| Injection, solution | Subcutaneous |
100 [iU]/1mL
|
| Solution | Subcutaneous |
100 U
|
| Solution | Subcutaneous |
100 unit / mL
|
| Solution | Subcutaneous |
1000 U
|
| Solution | Subcutaneous |
100000000 U
|
| Injection | Subcutaneous |
100 iu/ml
|
| Injection, solution | Subcutaneous |
100 iu/ml
|
| Injection, solution | Subcutaneous |
|
| Solution | Subcutaneous |
10000000 IU
|
| Injection, solution | Subcutaneous |
100 U/ML
|
| Injection | Subcutaneous |
|
| Injection, solution | Subcutaneous |
100 Units/mL
|
| Injection, solution | — |
100 Units/ml
|
| Injection, solution | Subcutaneous |
100 iu/1ml
|
| Injection, solution | Subcutaneous |
3.64 mg/ml
|
| Solution | Subcutaneous |
|
| Injection, solution | Subcutaneous |
|
| Injection, solution | Subcutaneous |
100 units/ml
|
| — | Subcutaneous |
|
| Injection, solution | Cutaneous; Parenteral |
|
| Injection, solution | Parenteral; Subcutaneous |
100 UI/ML
|
| Injection, solution | Parenteral; Subcutaneous |
300 IU/ML
|
| Solution | Subcutaneous |
300 U
|
| Injection, solution | Subcutaneous |
300 U/ML
|
| Injection, solution | Subcutaneous |
300 U/1mL
|
| Solution | Subcutaneous |
300 unit / mL
|
| Injection, solution | Subcutaneous |
300 Units/ml
|
| Solution | Subcutaneous |
30000000 U
|
| Solution | Subcutaneous |
3.64 mg
|
| Injection, solution | — |
100 iu/1ml
|
| Injection, solution | — |
|
| Injection, solution | — |
300 iu/1ml
|
Target Information